This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

SSRI Optimal Dose Remains at Issue

Article Abstract

Letter to the Editor

Sir: Drs. Gammon and Lane assert that Dr. Nemeroff erredwhen, in his review of drug treatment of depression, he saidthat most patients require more than 50 mg/day of sertraline, indistinction to other serotonin selective reuptake inhibitors,which require no more, usually, than the initial dosage: paroxetine20 mg/day and fluoxetine 20 mg/day. They even accuse Dr.Nemeroff of bias because his paper came from a presentationsupported by the makers of paroxetine. Dr. Nemeroff defendedhimself by referring to dose-response literature.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 58

Quick Links: Depression (MDD)